Cart
sales@molnova.com
(R)-Etomoxir sodium salt
CAS No. 828934-41-4
(R)-Etomoxir sodium salt ( (R)-(+)-Etomoxir (sodium salt) )
Catalog No. M19153 CAS No. 828934-41-4
(R)-Etomoxir sodium salt is R-form of Etomoxir. Etomoxir is a potent inhibitor of carnitine palmitoyltransferase-I (CPT-1).
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 50 | In Stock |
|
| 10MG | 80 | In Stock |
|
| 25MG | 140 | In Stock |
|
| 50MG | 250 | In Stock |
|
| 100MG | 410 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(R)-Etomoxir sodium salt
-
NoteResearch use only, not for human use.
-
Brief Description(R)-Etomoxir sodium salt is R-form of Etomoxir. Etomoxir is a potent inhibitor of carnitine palmitoyltransferase-I (CPT-1).
-
Description(R)-Etomoxir sodium salt is R-form of Etomoxir. Etomoxir is a potent inhibitor of carnitine palmitoyltransferase-I (CPT-1).
-
Synonyms(R)-(+)-Etomoxir (sodium salt)
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorCPT-1
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number828934-41-4
-
Formula Weight320.74
-
Molecular FormulaC15H18ClO4.Na
-
Purity98%
-
SolubilityH2O : 80 mg/mL 249.42 mM;
-
SMILES[Na+].[O-]C(=O)[C@@]1(CCCCCCOc2ccc(Cl)cc2)CO1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rupp H, et al. The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Herz. 2002 Nov;27(7):621-36.
molnova catalog
related products
-
TAK-700 (Orteronel)
Orteronel(TAK-700) was selected as a candidate for clinical evaluation.
-
N-Nornuciferine hydr...
N-Nornuciferine is an aporphine alkaloid in lotus leaf, significantly inhibits CYP2D6 (IC50: 3.76 μM, Ki: 2.34 μM).N-Nornuciferine strongly inhibits CYP2D6 activity but shows weak or no inhibition of the other four P450 isoenzymes (CYP2C19, CYP3A4, CYP2E1, CYP2C9). N-Nornuciferine competitively inhibits the CYP2D6-catalyzed dextromethorphan O-demethylation (Ki: 2.34 μM).
-
DMU2139
DMU2139 is a specific CYP1B1 inhibitor (CYP1B1 and CYP1A1 with IC50 of 9 nM and 795 nM, respectively).
